Shorter-course radiation better option for breast cancer patients than conventional schedule

Although survival and recurrence were similar, this approach is safer, more convenient for patients, and less costly, say researchers Giving higher doses per fraction of radiation therapy over a shorter time after breast cancer surgery significantly reduces the risk of side effects and improves quality of life compared with a ...

2024-09-12T15:18:21+00:0012 September 2024|Press release, The BMJ|

One dose of smallpox vaccine moderately effective in preventing mpox infection

Vaccine should be made available to communities at risk, say researchers One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) smallpox vaccine is moderately effective in preventing mpox infection and should be made available to communities at risk, finds a study published by The BMJ today. With mpox infections rising again across the ...

2024-09-12T15:15:58+00:0012 September 2024|Press release, The BMJ|

Prostate cancer rates across Europe since 1980 “indicative of overdiagnosis” say experts

Findings reinforce need for carefully planned screening programmes to minimise harms of overdiagnosis Rates of prostate cancer across Europe since 1980 are “indicative of overdiagnosis”, say researchers in a study published by The BMJ today. Overdiagnosis refers to the detection of harmless cancers that are unlikely to cause symptoms or death during ...

2024-09-05T09:09:56+00:005 September 2024|Press release, The BMJ|

Certain diabetes drugs might prevent dementia

But randomised controlled trials are needed to confirm these findings Sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes might prevent dementia, providing greater benefits with longer treatment, suggests a large study from Korea published by The BMJ today. As this study was observational, the researchers note that the effect size ...

2024-08-29T07:46:52+00:0029 August 2024|Press release, The BMJ|

New study provides further support for psilocybin’s potential to treat depressive symptoms

High dose psilocybin was the only psychedelic treatment to reduce depressive symptoms by more than placebo in antidepressant trials High doses of psilocybin - the active ingredient in magic mushrooms - appears to have a similar effect on depressive symptoms as the selective serotonin reuptake inhibitor (SSRI) drug escitalopram, suggests ...

2024-08-22T10:48:26+00:0022 August 2024|Press release, The BMJ|

Suicide rates among doctors have declined, but female doctors still at high risk

Results highlight ongoing need for research and prevention efforts among doctors, particularly women Suicide rates among doctors have declined over time, but are still significantly higher for female doctors compared with the general population, finds an analysis of evidence from 20 countries published by The BMJ today. The researchers acknowledge that physician ...

2024-08-22T10:45:24+00:0022 August 2024|Press release, The BMJ|
Go to Top